Magnetar Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Buy |
+27,245
| New | +$1.5M | 0.01% | 375 |
|
|
2024
Q4 | – | Sell |
-3,404
| Closed | -$239K | – | 623 |
|
|
2024
Q3 | $239K | Sell |
3,404
-5,412
| -61% | -$380K | 0.01% | 438 |
|
|
2024
Q2 | $726K | Buy |
+8,816
| New | +$726K | 0.02% | 300 |
|
|
2022
Q2 | – | Sell |
-3,169
| Closed | -$244K | – | 1667 |
|
|
2022
Q1 | $244K | Buy |
+3,169
| New | +$244K | ﹤0.01% | 1020 |
|
|
2021
Q2 | – | Sell |
-6,287
| Closed | -$475K | – | 1214 |
|
|
2021
Q1 | $475K | Buy |
6,287
+1,776
| +39% | +$134K | ﹤0.01% | 832 |
|
|
2020
Q4 | $396K | Buy |
+4,511
| New | +$396K | 0.01% | 592 |
|
|
2019
Q2 | – | Sell |
-4,242
| Closed | -$377K | – | 448 |
|
|
2019
Q1 | $377K | Buy |
+4,242
| New | +$377K | 0.01% | 290 |
|
|
2017
Q2 | – | Sell |
-16,485
| Closed | -$1.45M | – | 783 |
|
|
2017
Q1 | $1.45M | Buy |
+16,485
| New | +$1.45M | 0.02% | 227 |
|
|
2016
Q4 | – | Sell |
-7,272
| Closed | -$673K | – | 57 |
|
|
2016
Q3 | $673K | Buy |
+7,272
| New | +$673K | 0.01% | 299 |
|
|
2015
Q1 | – | Sell |
-89,689
| Closed | -$10.6M | – | 184 |
|
|
2014
Q4 | $10.6M | Buy |
89,689
+33,110
| +59% | +$3.92M | 0.17% | 55 |
|
|
2014
Q3 | $4.08M | Buy |
56,579
+4,800
| +9% | +$346K | 0.07% | 70 |
|
|
2014
Q2 | $3.22M | Buy |
+51,779
| New | +$3.22M | 0.05% | 72 |
|